IsoPlexis Corporation Common Stock
ISO was delisted on the 20th of March, 2023.
0 hedge funds and large institutions have $0 invested in IsoPlexis Corporation Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 30 closing their positions.
100% less funds holding
Funds holding: 30 → 0 (-30)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $28.3M → $0 (-$28.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 30
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NV
Northpond Ventures
Bethesda,
Maryland
|
-$13.7M |
| 2 |
PA
Perceptive Advisors
New York
|
-$6.35M |
| 3 |
GCM
Glenview Capital Management
New York
|
-$3.05M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$975K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$827K |
ISO Hedge Fund Activity: Q1 2023 in Review
0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in IsoPlexis Corporation Common Stock (ISO) for Q1 2023, worth a combined $0 — down 100% from $28.3M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of ISO and 0 opened new positions — a net loss of 30 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Northpond Ventures, exiting entirely with an estimated $13.7M sold.
- 0 institutional investors held IsoPlexis Corporation Common Stock (ISO) as of Q1 2023, down from 30 in Q4 2022.
- Funds reported $0 of IsoPlexis Corporation Common Stock stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new IsoPlexis Corporation Common Stock positions in Q1 2023 and 30 closed out, a net change of -30 holders.
- The largest IsoPlexis Corporation Common Stock seller in Q1 2023 was Northpond Ventures, an estimated $13.7M sold.
Based on aggregated 13F filings for Q1 2023.